Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 229
Selected: 0
NCT IDTitle
NCT00126854High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation
NCT04175769A Nutritional Supplement to Support People With Non-small Cell Lung Cancer
NCT01157052Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients
NCT00309504Pulse Sequence Development on 3T Magnetic Resonance Imaging/Spectroscopy
NCT00316563Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study
NCT05775146SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases
NCT01747512An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)
NCT05031065Prognostic Indicators for Radiation-induced Breast Fibrosis
NCT00563407Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy
NCT01740271A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients
NCT00123799Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection
NCT00279721Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer.
NCT00122252Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) Contouring in Prostate Cancer to Improve the Possibilities for Intensity Modulated RadioTherapy (IMRT) Dose Escalation
NCT00291304Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma
NCT04677049Study of Niacin in Glioblastoma
NCT02052102Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart
NCT01488968Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients
NCT06789081GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)
NCT00469222Hypofractionated Radiotherapy for Small Cell Lung Cancer
NCT00130936Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates
NCT00124488Comparison of Tomotherapy Versus Intensity-modulated Step-and-shoot and Conventional Radiation Treatment Plans for Patients With Locally-advanced Squamous Cell Carcinoma of the Cervix
NCT00566410A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours
NCT00123812Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With Radiotherapy
NCT00351637Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients
NCT00771381A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer
NCT05413473Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)
NCT00351572Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients
NCT06001125Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)
NCT05421416Loratadine for the Prevention of G-CSF-related Bone Pain
NCT04765514Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients
NCT00765986Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy
NCT00469196Tomotherapy Treatment for Mesothelioma
NCT00128999Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer
NCT00690963Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating
NCT00123864Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function
NCT03622164Unilateral Neck Radiotherapy in Head and Neck Cancer
NCT00469066Cone Beam CT Scanning in Lung and Bladder Cancer.
NCT00469534Minimized Time to Beam in Patients With High Grade Gliomas
NCT03469011A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.
NCT00922519Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body Positron Emission Tomography (PET) Scans for Imaging Bone
NCT03391973Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)
NCT00168181Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients
NCT05709535PSMA-PET/CT Registry
NCT00126828Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer
NCT01411072Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer
NCT00489060A Randomized Trial of External Beam Radiotherapy Versus Cryoablation in Patients With Localized Prostate Cancer
NCT00414089Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHL
NCT00255229Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea
NCT01830101A Phase III Study of Re-Irradiation in Recurrent Glioblastoma
NCT00126867Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment